THE CYCLOPHOSPHAMIDE, HEXAMETHYLMELAMINE, 5 FLUOROURACIL (CHF) REGIMEN IN THE TREATMENT OF ADVANCED AND RECURRENT OVARIAN-CANCER

被引：17

作者：

POSADA, JG

MARANTZ, AB

YEUNG, KY

SMITH, FP

DELGADO, G

EDWARDS, BK

SCHEIN, PS

机构：

[1] GEORGETOWN UNIV HOSP,DEPT MED & GYNECOL ONCOL,WASHINGTON,DC 20007

[2] NCI,DIV CANC TREATMENT,BIOMETR RES BRANCH,BETHESDA,MD 20205

来源：

GYNECOLOGIC ONCOLOGY | 1985年 / 20卷 / 01期

关键词：

D O I：

10.1016/0090-8258(85)90121-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：23 / 31

页数：9

共 21 条

[1]

ARMITAGE P, 1971, STAT METHODS MED RES, P135

[2]

BARLOW JJ, 1975, CANCER TREAT REP, V60, P527

[3]

CARMOPEREIRA J, 1981, CANCER, V48, P1947, DOI 10.1002/1097-0142(19811101)48:9<1947::AID-CNCR2820480906>3.0.CO

[4]

2-M

[5]

Day T G Jr, 1975, Semin Oncol, V2, P217

[6]

DELGADO G, 1979, P AM ASSOC CANC RES, V20, P434

[7] PROSPECTIVE-STUDY WITH HEXA-CAF COMBINATION IN OVARIAN-CARCINOMA [J].

DEPALO, G ;

DEMICHELI, R ;

VALAGUSSA, P ;

DELENA, M ;

VILLA, E ;

DIRE, F ;

PILOTTI, S .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1981, 5 (03) :157-161

[8]

FISHER RI, 1977, CANCER-AM CANCER SOC, V39, P967, DOI 10.1002/1097-0142(197702)39:2+<967::AID-CNCR2820390736>3.0.CO

[9]

2-G

[10]

GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203

← 1 2 3 →